***Registration is Now Open for Cambridge Healthtech Institutes
Structure-Based Drug Design: Sophisticated Approaches to Drug Discovery
June 4-5, 2009
Royal Sonesta Hotel, Cambridge, Massachusetts
Topics of discussion include:
- Target Structure-Guided Drug Discovery
- Feeding SBDD with Biochemical and Biophysical Information
- Ligand-Based Predictions Applied to Drug Design
- SBDD and Computational Chemistry Methods: A Marriage of
- SBDD of Pharmacological Chaperons
Alex Aronov, Ph.D., Vertex Pharmaceuticals, Inc.
Xavier Barril, Ph.D. , ICREA Research Universitat de Barcelona
Alex Burgin, Ph.D., deCODE Biostructures
Miles Congreve, Ph.D., Heptares Therapeutics Ltd.
José Duca, Ph.D., Schering Plough Research Institute
Stefan Geschwindner, Ph.D., AstraZeneca R&D Mölndal
Ajay N. Jain, Ph.D., University of California, San Francisco
Paul Labute, Ph.D., Computing Group (CCG)
Dr. Richard J. Law, Evotec AG
Brian B. Masek, Ph.D., Tripos International
Mark Murcko, Ph.D., Vertex Pharmaceuticals, Inc.
Sander Nabuurs, Ph.D., Radboud University Nijmegen
Enrico O. Purisima, Ph.D., National Research Council of Canada
Dagmar Ringe, Ph.D., Brandeis University
Suo-Bao Rong, Ph.D., Pfizer Global R&D
Tomi Sawyer, Ph.D., AILERON Therapeutics; Editor-in-Chief, Chemical Biology
& Drug Design
Andrew D. Scott, Ph.D., Pfizer Global Research and Development
Suresh Singh, Ph.D., Vitae Pharmaceuticals
Raymond C. Stevens, Scripps Research Institute
Gergely Toth, Ph.D., Elan Pharmaceuticals
Marcel Verdonk, Ph.D., Astex Therapeutics, Ltd.
Markus Wagener, Ph.D., Schering-Plough Research Institute
W. Patrick Walters, Ph.D., Vertex Pharmaceuticals, Inc.
Plus! Pre-Conference Workshop, Wednesday, June 3
Designing Kinase Inhibitors*
- Challenges of Crystal Structures
- X-Ray Crystallography
- Target Immobilized NMR Screening
*Separate registration is required.
Arrive early to attend...
Protein Kinase Targets
Interested in Sponsorships and Exhibit Opportunities?
Manager, Business Development
E-mail: kfitzgerald from healthtech.com
Special Pricing is Available to Attend Both the Structure-Based Drug Design
and Protein Kinase Conferences.
Learn more and register at www.healthtech.com/SBD/overview.aspx
Otherwise, call CHI at 781-972-5400.